Search - tctmd.com

Displaying 21 - 40 of 85

Sort: Relevancy | Date

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Industry News

Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death

October 02, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Shelley Wood

September 26, 2017

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Daily News

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

L.A. McKeown

September 25, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

Todd Neale

September 19, 2017

News Daily News

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Michael O'Riordan

September 18, 2017

News Industry News

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

September 15, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Conference News ESC 2017

Under Pressure: PRECISION Substudy Shows Adverse BP Effects of Ibuprofen

L.A. McKeown

August 30, 2017

News Conference News ESC 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

Todd Neale

August 29, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Daily News

Readmissions After Acute MI Not Only Confined to the Elderly

Yael L. Maxwell

August 09, 2017

News Daily News

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Michael O'Riordan

August 08, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

News Daily News

Elevated Cardiovascular Risk May Linger for Several Years After a Severe Infection

Todd Neale

August 02, 2017

News Daily News

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Michael O'Riordan

August 01, 2017

Advertisement

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Generic ARBs Linked to Increased Adverse Events

Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Under Pressure: PRECISION Substudy Shows Adverse BP Effects of Ibuprofen

P2Y12 Inhibitor Pretreatment Questioned in STEMI

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Readmissions After Acute MI Not Only Confined to the Elderly

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Elevated Cardiovascular Risk May Linger for Several Years After a Severe Infection

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content